Risk Factors of Developing Long-Lasting Breast Pain After Breast Cancer Radiotherapy

Journal Article · Tue May 01 04:00:00 EDT 2012 · International Journal of Radiation Oncology, Biology and Physics

DOI:https://doi.org/10.1016/J.IJROBP.2011.05.065· OSTI ID:22056303

Lundstedt, Dan ^[1]; Gustafsson, Magnus ^[1]; Steineck, Gunnar ^[1]; Malmstroem, Per ^[2]; Alsadius, David ^[1]; Sundberg, Agnetha ^[3]; Wilderaeng, Ulrica ^[1]; Holmberg, Erik ^[4]; Johansson, Karl-Axel ^[3]; Karlsson, Per ^[5]

---

1. Division of Clinical Cancer Epidemiology, Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg (Sweden)
2. Skane Department of Oncology, Skane University Hospital, Lund (Sweden)
3. Department of Therapeutic Radiation Physics, Sahlgrenska University Hospital, Gothenburg (Sweden)
4. Oncologic Centre, Sahlgrenska University Hospital, Gothenburg (Sweden)
5. Department of Oncology, Sahlgrenska University Hospital, Gothenburg (Sweden)

Purpose: Postoperative radiotherapy decreases breast cancer mortality. However, studies have revealed a long-lasting breast pain among some women after radiotherapy. The purpose of this study was to identify risk factors that contribute to breast pain after breast cancer radiotherapy. Methods and Materials: We identified 1,027 recurrence-free women in two cohorts of Swedish women treated for breast cancer. The women had breast-conserving surgery and postoperative radiotherapy, the breast was treated to 48 Gy in 2.4-Gy fractions or to 50 Gy in 2.0-Gy fractions. Young women received a boost of up to 16 Gy. Women with more than three lymph node metastases had locoregional radiotherapy. Systemic treatments were given according to health-care guidelines. Three to 17 years after radiotherapy, we collected data using a study-specific questionnaire. We investigated the relation between breast pain and potential risk modifiers: age at treatment, time since treatment, chemotherapy, photon energy, fractionation size, boost, loco-regional radiotherapy, axillary surgery, overweight, and smoking. Results: Eight hundred seventy-seven women (85%) returned the questionnaires. Among women up to 39 years of age at treatment, 23.1% had breast pain, compared with 8.7% among women older than 60 years (RR 2.66; 95% CI 1.33-5.36). Higher age at treatment (RR 0.96; 95% CI 0.94-0.98, annual decrease) and longer time since treatment (RR 0.93; 95% CI 0.88-0.98, annual decrease) were related to a lower occurrence of breast pain. Chemotherapy increased the occurrence of breast pain (RR 1.72; 95% CI 1.19-2.47). In the multivariable model only age and time since treatment were statistically significantly related to the occurrence of breast pain. We found no statistically significant relation between breast pain and the other potential risk modifiers. Conclusions: Younger women having undergone breast-conserving surgery with postoperative radiotherapy report a higher occurrence of long-lasting breast pain compared to older women. Time since treatment may decrease the occurrence of pain.

• OSTI ID: 22056303
• Journal Information: International Journal of Radiation Oncology, Biology and Physics, Journal Name: International Journal of Radiation Oncology, Biology and Physics Journal Issue: 1 Vol. 83; ISSN IOBPD3; ISSN 0360-3016
• Country of Publication: United States
• Language: English

Related Subjects

62 RADIOLOGY AND NUCLEAR MEDICINE
CHEMOTHERAPY
FRACTIONATION
HAZARDS
LYMPH NODES
MAMMARY GLANDS
METASTASES
MORTALITY
NEOPLASMS
PAIN
PHOTONS
RADIOTHERAPY
SURGERY
SWEDEN
WOMEN